Selank is a synthetic peptide derived from the endogenous protein Tuftsin, which is a natural immunomodulatory peptide found in human and animal tissues. Selank was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences and has shown promising results as a neuropeptide with a unique combination of anxiolytic, neuroprotective, and cognitive enhancing properties.

Selank has a heptapeptide sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro) and is considered an anxiolytic peptide drug with nootropic effects. It has a high affinity for binding to the GABAergic, serotonergic, and dopaminergic systems in the brain, which are responsible for regulating mood, stress response, learning, and memory. Selank has been shown to modulate the expression of brain-derived neurotrophic factor (BDNF), which is essential for neuronal growth and synaptic plasticity.

 

Research Applications:

Selank peptide is intended for research purposes only and is not approved for human consumption. It is primarily used in scientific research to study its potential therapeutic applications, including but not limited to:

• Anxiety and stress-related disorders
• Cognitive impairment and memory deficits
• Neurodegenerative disorders
• Immune system regulation

Selank Dosage:

This product is intended for research purposes only and is not approved for human or veterinary use. The information provided is for informational purposes only and should not be considered as medical advice or endorsement of any treatment or therapy. Consult with a healthcare professional before using any peptide for therapeutic purposes.